Do you want to read an article? Please log in or register.
Observational, open-label, non-randomized study on the efficacy of onabotulinumtoxinA in the treatment of nummular headache: The pre-numabot study
Migraine and Headache
Related content
Migraine and Headache
Long-term study of the efficacy and safety of OnabotulinumtoxinA for the prevention of chronic migraine: COMPEL study
J Headache Pain.
Blumenfeld AM, Stark RJ, Freeman MC, Orejudos A, Manack Adams A
doi: 10.1186/s10194-018-0840-8.
RECOMMENDED
Migraine and Headache
Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study)
Cephalalgia.
Brandes JL, Klise S, Krege JH, Case M, Khanna R, Vasudeva R, Raskin J, Pearlman EM, Kudrow D
doi: 10.1177/0333102419864132.
Migraine and Headache
STOP 301: A Phase 3, open-label study of safety, tolerability, and exploratory efficacy of INP104, Precision Olfactory Delivery (POD® ) of dihydroergotamine mesylate, over 24/52 weeks in acute treatment of migraine attacks in adult patients
Headache
Smith TR, Winner P, Aurora SK, Jeleva M, Hocevar-Trnka J, Shrewsbury SB
doi: 10.1111/head.14184
Migraine and Headache
FORWARD Study: Evaluating the Comparative Effectiveness of OnabotulinumtoxinA and Topiramate for Headache Prevention in Adults With Chronic Migraine
Headache.
Rothrock JF, Adams AM, Lipton RB, Silberstein SD, Jo E, Zhao X, Blumenfeld AM, FORWARD Study investigative group.
doi: 10.1111/head.13653.
Migraine and Headache
Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double-Blind Placebo-Controlled Phase 3 Clinical Studies
Headache.
Ashina M, Vasudeva R, Jin L, Lombard L, Gray E, Doty EG, Yunes-Medina L, Kinchen KS, Tassorelli C
doi: 10.1111/head.13636.
Migraine and Headache
An Open-Label Study Evaluating the Pharmacokinetics and Safety of Diclofenac Potassium for Oral Solution for the Acute Treatment of MWA or MWoA in Pediatric Participants
Headache.
McVige JW, Hogan RM, Shanahan CM, Amend DL, Ferger SM
doi: 10.1111/head.13922.
RECOMMENDED
Migraine and Headache
A Randomized Trial to Evaluate OnabotulinumtoxinA for Prevention of Headaches in Adolescents With Chronic Migraine
★ 1
Recommended by
Prof. Dr Claudio Gobbi, Faculty Member
Headache.
Winner PK, Kabbouche M, Yonker M, Wangsadipura V, Lum A, Brin MF
doi: 10.1111/head.13754.
RECOMMENDED
Migraine and Headache
Differential efficacy of non-invasive vagus nerve stimulation for the acute treatment of episodic and chronic cluster headache: A meta-analysis
Cephalalgia.
de Coo IF, Marin JC, Silberstein SD, Friedman DI, Gaul C, McClure CK, Tyagi A, Liebler E, Tepper SJ, Ferrari MD, Goadsby PJ
doi: 10.1177/03331024
Further Publications NeurologyFurther Publications Psychiatry
Efficacy and cost-effectiveness of an adjunctive personalised psychosocial intervention in treatment-resistant maintenance opioid agonist therapy: a pragmatic, open-label, randomised controlled trial
Lancet Psychiatry.
Marsden J, Stillwell G, James K, Shearer J, Byford S, Hellier J, Kelleher M, Kelly J, Murphy C, Mitcheson L
doi: 10.1016/S2215-0366(19)30097-5.